Nebulized Lidocaine to Prevent Cough at Emergence From Anesthesia
Not Applicable
- Conditions
- Cough, General Anesthesia, Extubation, Lidocaine, Sore Throat
- Interventions
- Drug: Normal saline
- Registration Number
- NCT04000633
- Lead Sponsor
- Mongi Slim Hospital
- Brief Summary
our study aimed to evaluate the effect of nebulized lidocaine to decrease the incidence of cough and sore throat after extubation after surgeries requiring endotracheal intubation.
- Detailed Description
our study aimed to evaluate the effect of nebulized lidocaine to decrease the incidence of cough and sore throat after extubation after surgeries requiring endotracheal intubation.
This randomized controlled study will compare the effect of Lidocaine and placebo nebulization in the immediate pre operative period in order to evaluate the effectiveness in reducing post extubation cough and sore throat.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
- age>18 years
- ASA status I or II
Exclusion Criteria
- Unexpected difficult laryngoscopy
- Surgery>3 hours
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo group Normal saline the patients of this group will recieve nebulization of 5 ml of normal saline prior to induction of general anesthesia lidocaine group Lidocaine 2% the patients of this group will recieve nebulization of 5 ml of 2% lidocaine prior to induction of general anesthesia
- Primary Outcome Measures
Name Time Method incidence of cough at emergence from general anesthesia 30 minutes after the end of surgery evaluation of incidence of cough at emergence from general anesthesia
- Secondary Outcome Measures
Name Time Method incidence of sore throat 24 hours after tracheal extubation evaluation of incidence of sore throat
Trial Locations
- Locations (1)
Mongi Slim Hospital
🇹🇳La Marsa, Tunis, Tunisia